维普中文期刊产品整合服务
74篇 您的检索式:作者名="Angermayr"
    题名 作者 年代 出处 被引量
1炼铁、炼钢和连铸电气自动化技术及创新显示文摘西门子奥钢联能够为炼铁和炼钢厂提供包括连铸机在内的全面的自动化解决方案,可靠的供电、驱动解决方案连同创新技术、过程控制和过程优化系统确保了生产的顺利进行以及对能源和原材料的合理利用。炼铁和炼钢工艺中达到成本效益最大化和最优控制的关键因素是技术专业知识在以往的解决方案获得了验证,确保为小规模的更新改造以及整套新建生产设备提供最优化解决方案。介绍了西门子奥钢联经验证的,具有成本效益的全面的电气自动化解决方案,它能够根据钢铁生产者的需求量身定做。Peter Schanza Barbara Angermayr Peter Juza 2010钢铁2010,45,3:3
2Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents显示文摘Bernhard Angermayr Manfred Cejna Franz Koenig Franz Karnel Franz Hackl Alfred Gangl Markus Peck-Radosavljevic 2003Hepatology2003,,4:2
3Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt 显示文摘Angermayr B Cejna M Karnel F 2003Gut2003,52,6:1
4Inhibi- tion of VEGF receptor-2 decreases the development of hyper- dynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats 显示文摘FERNANDEZ M MEJIAS M ANGERMAYR B 2005Hepatol2005,43,:1
5Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats 显示文摘Fernandez M Mejias M Angermayr B 2005J Hepatol2005,43,1:1
6Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats显示文摘Thomas Reiberger Bernhard Angermayr Philipp Schwabl Natascha Rohr-Udilova Markus Mitterhauser Alfred Gangl Markus Peck-Radosavljevic 2009Journal of Hepatology2009,,5:1
7Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats显示文摘 Mejias M Angermayr B 2005J Hepatol2005,43,:1
8Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt 显示文摘Angermayr B Cejna M Karnel F 2003Gut2003,52,6:1
9Child - Pugh Versus MELD Score in Predicting Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt显示文摘Angermayr B Cejna M Karnel F 2003Gut2003,52,:1
10Sor- afenib attenuates the portalhypertensive syndrome in partial portal vein ligated rats 显示文摘REIBERGER T ANGERMAYR B SCHWABL P 2009Hepatol2009,51,:1
11Inhibition of VEGF receptor-2 decreases the development of hyperdy- namic splanchnic circulation and portal-systemic collater- al vessels in portal hypertension rats显示文摘Fernandez M Mejias M Angermayr B 2005J Hepatol2005,43,1:1
12Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats显示文摘Fernandez M Mejias M Angermayr B 0,,:1
13Sorafenib at- tenuates the portalhypertensive syndrome in partial portal vein ligated rats 显示文摘Reiberger T Angermayr B Schwabl P 2009Hepatol2009,51,5:1
14Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats 显示文摘Reiberger T Angermayr B Schwabl P 2009J Hepatol2009,51,5:1
15Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats 显示文摘Fernandez M Mejias M Angermayr B 2005J Hepatol2005,43,1:1
16Inhibition of VEGF receptor-2 decreases the development of hyperdynamie splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats 显示文摘Fernandez M Mejias M Angermayr B 2005J Hepatol2005,43,:1
17NAD (P) H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats 显示文摘Angermayr B Fernandez M Mejias M 2007Gut2007,56,:1
18Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents 显示文摘Angermayr B Cejna M Koenig F 2003Hepatology2003,38,4:1
19ePTFE-Covered Stent-Grafts for Revision of Obstructed Transjugular Intrahepatic Portosystemic Shunt显示文摘Manfred Cejna Markus Peck-Radosavljevic Siegfried Thurnher Maria Schoder Thomas Rand Bernhard Angermayr Johannes Lammer 2002CardioVascular and Interventional Radiology2002,,5:1
20Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients显示文摘Valentin Fuhrmann Nikolaus Kneidinger Harald Herkner Gottfried Heinz Mariam Nikfardjam Anja Bojic Peter Schellongowski Bernhard Angermayr Reinhard Kitzberger Joanna Warszawska Ulrike Holzinger Peter Schenk Christian Madl 2009Intensive Care Medicine2009,,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费